Pathophysiology of Type 2 Diabetes Mellitus
Open accessThe DOI matches its Crossref record; 293 of the 297 references it cites were found in a registry or an index.
Abstract
Type 2 Diabetes Mellitus (T2DM), one of the most common metabolic disorders, is caused by a combination of two primary factors: defective insulin secretion by pancreatic β-cells and the inability of insulin-sensitive tissues to respond appropriately to insulin. Because insulin release and activity are essential processes for glucose homeostasis, the molecular mechanisms involved in the synthesis and release of insulin, as well as in its detection are tightly regulated. Defects in any of the mechanisms involved in these processes can lead to a metabolic imbalance responsible for the development of the disease. This review analyzes the key aspects of T2DM, as well as the molecular mechanisms and pathways implicated in insulin metabolism leading to T2DM and insulin resistance. For that purpose, we summarize the data gathered up until now, focusing especially on insulin synthesis, insulin release, insulin sensing and on the downstream effects on individual insulin-sensitive organs. The review also covers the pathological conditions perpetuating T2DM such as nutritional factors, physical activity, gut dysbiosis and metabolic memory. Additionally, because T2DM is associated with accelerated atherosclerosis development, we review here some of the molecular mechanisms that link T2DM and insulin resistance (IR) as well as cardiovascular risk as one of the most important complications in T2DM.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures







Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“T2D is considered a polygenic condition with considerable heterogeneity in degrees of insulin deficiency and resistance and accounts for >90% of all cases of DM.32”
From American Association of Clinical Endocrinology Clinical Practice Guideline: Developing a Diabetes Mellitus Comprehensive Care Plan-2022 Update. (2022) · cites this paper as [32]
The cited source says what the claim attributes to it.
In the citing paper
“Likewise, diabetes is secondary to altered glucose homeostasis [67], and this study suggests a critical role for NHE3 in the regulation of SGLT1, which is the predominant intestinal glucose transporter.”
From Regulation of Enterocyte Brush Border Membrane Primary Na-Absorptive Transporters in Human Intestinal Organoid-Derived Monolayers (2024) · cites this paper as [67]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III)
Grundy, S. M., Becker, D. M., Clark, L. T., Cooper, R., Denke, M. A., Howard, J. L., Hunninghake, D. B., Illingworth, D. R., Luepker, R. V., McBride, P. E., et al. (2002) · Civil War Book Review · Cited by 12,198
Yusuf, S., Hawken, S., Ôunpuu, S., Dans, T., Avezum, A., Lanas, F., McQueen, M., Budaj, A., Pais, P., Varigos, J., et al. (2004) · The Lancet · doi:10.1016/s0140-6736(04)17018-9 · Cited by 12,026
Mootha, V. K., Lindgren, C. M., Eriksson, K.-F., Subramanian, A., Sihag, S., Lehar, J., Puigserver, P., Carlsson, E., Ridderstråle, M., Laurila, E., et al. (2003) · Nature Genetics · doi:10.1038/ng1180 · Cited by 10,197
Inflammation and metabolic disorders
Hotamisligil, G. S. (2006) · Nature · doi:10.1038/nature05485 · Cited by 9,199 · cited 2×
“A critical component of T2DM is a chronic low-grade inflammatory state, referred to as “metaflammation” [250].”
Background10-year follow-up of intensive glucose control in type 2 diabetes
Holman, R. R., Paul, S. K., Bethel, M. A., Matthews, D. R., & Neil, H. A. W. (2008) · New England Journal of Medicine · doi:10.1056/nejmoa0806470 · Cited by 7,751 · cited 1×
“Among them, the UKPDS post-trial study and Steno-2 trial showed that specifically early glycemic interventions prevent diabetic complication and has a marked decrease in CVD endpoints in patients that received either standard or intensive treatment following their diagnosis [84].”
BackgroundHaffner, S. M., Lehto, S., Rönnemaa, T., Pyörälä, K., & Laakso, M. (1998) · New England Journal of Medicine · doi:10.1056/nejm199807233390404 · Cited by 7,000
ROS function in redox signaling and oxidative stress
Schieber, M., & Chandel, N. S. (2014) · Current Biology · doi:10.1016/j.cub.2014.03.034 · Cited by 6,931 · cited 1×
“In these circumstances, as a consequence of nutrient overload, electron supply to the mitochondrial ETC increases and the electron excess is transferred to oxygen generating O2− and subsequent hydrogen peroxide [127].”
BackgroundMetabolic Endotoxemia Initiates Obesity and Insulin Resistance
Cani, P. D., Amar, J., Iglesias, M. A., Poggi, M., Knauf, C., Bastelica, D., Neyrinck, A. M., Fava, F., Tuohy, K. M., Chabo, C., et al. (2007) · Diabetes · doi:10.2337/db06-1491 · Cited by 6,638 · cited 1×
“A high-fat diet can induce up to threefold lipopolysaccharide (from Gram-negative bacteria) production in mice models, thereby contributing to low-grade inflammation and insulin resistance [76,77].”
BackgroundEckel, R. H., Alberti, K., Grundy, S. M., & Zimmet, P. Z. (2010) · The Lancet · doi:10.1016/s0140-6736(09)61794-3 · Cited by 6,295
Research works printed but not linked: 1
- Simmons D. Epigenetic Influences and Disease Nat. Educ. 2008 1 6
Cited by
Items 601–700 of 1,005
Oliveira, M. S., Costa, G. D., Rodrigues, G. G., de Castro, H. U. D., & Sampaio, V. V. L. (2023) · Brazilian Journal of Health Review · doi:10.34119/bjhrv6n5-457 · Cited by 73
Saldívar‐González, F. I., Navarrete‐Vázquez, G., & Medina‐Franco, J. L. (2023) · Frontiers in Pharmacology · doi:10.3389/fphar.2023.1276444 · Cited by 12
Mechanisms of action of natural products on type 2 diabetes
Wang, T., Wang, Y., Shi, M.-Y., & Liu, L. (2023) · World Journal of Diabetes · doi:10.4239/wjd.v14.i11.1603 · Cited by 17
Durma, A. D., Saracyn, M., Kołodziej, M., Jóźwik−Plebanek, K., Dmochowska, B., Kapusta, W., Żmudzki, W., Mróz, A., Kos‐Kudła, B., & Kamiński, G. (2023) · Cancers · doi:10.3390/cancers15225466 · Cited by 17
Talearngkul, R., Sae‐tan, S., & Sirivarasai, J. (2023) · Foods · doi:10.3390/foods12234373 · Cited by 19
“Gut dysbiosis is primarily associated with compositional and functional alterations of the gut microbiome, resulting in decreased microbiota diversity, loss of beneficial microorganisms, or an overgrowth of harmful microorganisms [2].”
BackgroundInfluentialYang, Z. M., Gan, W., Dai, L., Zhang, H., Zhang, Y., Yang, Q., Feng, Y., Yang, J., Fu, C., & Li, D. (2023) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.3c17711 · Cited by 16
Swargiary, D., Kashyap, B., Sarma, P., Ahmed, S. A., Gurumayum, S., Barge, S., Basumatary, D., & Borah, J. C. (2024) · Fitoterapia · doi:10.1016/j.fitote.2023.105803 · Cited by 16
Obaid, A. A., Mujalli, A., Farrash, W. F., Tayeb, R. H., Bougeis, R. J. M., Aljehani, A., Alshehri, B. Y., Sharaf, S., & Alqurashi, S. (2024) · Diabetes Metabolic Syndrome and Obesity · doi:10.2147/dmso.s445314 · Cited by 16
Chukwuma, C. I. (2024) · Plants · doi:10.3390/plants13020191 · Cited by 14
“Obesity, on the other hand, remains one of the main risk factors of type 2 diabetes because it predisposes people to insulin resistance and metabolic syndrome [3].”
BackgroundInfluentialZolotova, D., Teterovska, R., Bandere, D., Lauberte, L., & Niedra, S. (2024) · Plants · doi:10.3390/plants13071021 · Cited by 17
“This metabolic disorder results from both inadequate insulin secretion by pancreatic β -cells and diminished tissue responsiveness to insulin [4].”
BackgroundFarahbod, K., Slouha, E., Gerts, A., Rezazadah, A., Clunes, L. A., & Kollias, T. F. (2024) · Cureus · doi:10.7759/cureus.56737 · Cited by 19
Kurniawan, R., Taslim, N. A., Hardinsyah, H., Syauki, A. Y., Idris, I., Aman, A. M., Permatasari, H. K., Wiyarta, E., Surya, R., Mayulu, N., et al. (2024) · Future Foods · doi:10.1016/j.fufo.2024.100354 · Cited by 16
Zinc and pH modulate the ability of insulin to inhibit aggregation of islet amyloid polypeptide
McCalpin, S. D., Khemtémourian, L., Suladze, S., Ivanova, M. I., Reif, B., & Ramamoorthy, A. (2024) · Communications Biology · doi:10.1038/s42003-024-06388-y · Cited by 18
Asadi, M., Ahangari, M. M., Iraji, A., Azizian, H., Nokhbehzaim, A., Bahadorikhalili, S., Mojtabavi, S., Faramarzi, M. A., Nasli‐Esfahani, E., Larijani, B., et al. (2024) · Scientific Reports · doi:10.1038/s41598-024-68176-2 · Cited by 14
Gamal, M., Awad, M. A., Shadidizaji, A., Ibrahim, M. A., Ghoneim, M. A., & Warda, M. (2024) · The Journal of Nutritional Biochemistry · doi:10.1016/j.jnutbio.2024.109775 · Cited by 15
Karimi, M., Vakili, K. G., Rashidian, P., Razavi-Amoli, S.-K., Akhbari, M., & Kazemi, K. (2024) · Frontiers in Clinical Diabetes and Healthcare · doi:10.3389/fcdhc.2024.1466408 · Cited by 17
Gong, P., Wang, X., Han, Y., Long, H., Yang, W., Chen, F., Cui, M., Zhai, W., Zheng, B., & Chen, X. (2024) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2024.137596 · Cited by 15
Polyphenolic Compounds in Fabaceous Plants with Antidiabetic Potential
Guerrero-Becerra, L., Morimoto, S., Arellano-Ordoñez, E., Morales-Miranda, A., Guevara-González, R. G., Feregrino‐Pérez, A. A., & Lomas‐Soria, C. (2025) · Pharmaceuticals · doi:10.3390/ph18010069 · Cited by 18
“This causes membrane depolarization and opening of voltage-gated calcium channels, allowing Ca2+ to enter the cell, triggering insulin exocytosis, leading to the release of insulin into the bloodstream [16].”
Ghasemi, M., Mahdavi, M. R., Dehghan, M., Eftekharian, M., Mojtabavi, S., Faramarzi, M. A., Iraji, A., & Al‐Harrasi, A. (2025) · Scientific Reports · doi:10.1038/s41598-024-83917-z · Cited by 16
Elfaki, I., Mir, R., Abuduhier, F. M., Alotaibi, M. A., Alalawy, A. I., Barnawi, J., Babakr, A. T., Mir, R., Tayeb, F. J., Mirghani, H. O., et al. (2021) · Current Issues in Molecular Biology · doi:10.3390/cimb43030130 · Cited by 18
“T2DM represents more than 90% of all cases of DM [7].”
BackgroundWu, X., Huang, S., Shi, Y., Shen, Y., Tu, W., Leng, Y., & Zhao, Q. (2022) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2022.114171 · Cited by 14
Kausar, M. A., Anwar, S., Eltayb, W. A., Kuddus, M., Khatoon, F., El‐Arabey, A. A., Khalifa, A. M., Rizvi, M. R., Najm, M. Z., Thakur, L., et al. (2022) · Molecules · doi:10.3390/molecules27154980 · Cited by 15
“The second is type II DM, where the insulin secretion is reduced or resistance is developed against insulin, thereby hindering its action [8].”
BackgroundYang, Y., & Wang, Q. (2023) · Scientific Reports · doi:10.1038/s41598-023-35908-9 · Cited by 16
D’Haese, S., Verboven, M., Evens, L., Deluyker, D., Lambrichts, I., Eijnde, B. O., Hansen, D., & Bito, V. (2023) · Nutrients · doi:10.3390/nu15183950 · Cited by 19
“Interestingly, insulin resistance is known to induce FFA release from adipose tissue, which can be taken up by liver cells and stored as triglycerides after re-assembling [61].”
BackgroundPrevention and Management Strategies of Pre-Diabetes
Mohajan, D., & Mohajan, H. K. (2023) · Frontiers in Management Science · doi:10.56397/fms.2023.10.04 · Cited by 23
3D printed medicine for the management of chronic diseases: The road less travelled
Varghese, R., Salvi, S., Sood, P., Karsiya, J., & Kumar, D. (2021) · Annals of 3D Printed Medicine · doi:10.1016/j.stlm.2021.100043 · Cited by 14
Kaur, I., Das, S., Chandel, S., & Chandel, S. (2025) · Diabetes & Metabolic Syndrome: Clinical Research & Reviews · doi:10.1016/j.dsx.2025.103185 · Cited by 13
Chua, R. E. C., Lau, Y., Ang, W. W., Boey, A. A. Y. F., & Lau, S. T. (2024) · Journal of Diabetes · doi:10.1111/1753-0407.70002 · Cited by 14
Diabetic Wound: Pathophysiology, Complications and Treatment Strategies
Chauhan, S., Gulia, M., Singh, R. P., & Jhawat, V. (2023) · Current Protein and Peptide Science · doi:10.2174/0113892037276171231016103320 · Cited by 17
Zhong, H., Luo, L., Wang, X., & Xiao, Y. (2024) · Laboratory Medicine · doi:10.1093/labmed/lmae052 · Cited by 17
Yen, Y., Yen, F., Ko, F., Wei, J. C., Huang, Y., Yu, T., Hwu, C., & Hsu, C. (2024) · Diabetes Obesity and Metabolism · doi:10.1111/dom.15908 · Cited by 14
Micheliolide mitigates diabetic nephropathy by modulating oxidative stress and inflammation in rats
Zhang, C., Sun, B., Wang, L., Korla, P. K., & Liu, C. (2025) · Phytomedicine · doi:10.1016/j.phymed.2025.157025 · Cited by 14
Shaw, S. K., Sengupta, S., Jha, R., Pattanaik, C., Behera, H., Barik, P. K., Meher, D., Sarangi, R., & Devadas, S. (2025) · Frontiers in Immunology · doi:10.3389/fimmu.2025.1603484 · Cited by 19
Lin, Y., Yoo, J. M., Li, D., Heo, Y., Okumura, M., Won, H., Vendruscolo, M., Lim, M. H., & Lee, Y. (2025) · Translational Neurodegeneration · doi:10.1186/s40035-025-00507-3 · Cited by 17
“T2D is a chronic metabolic disorder characterized by insulin resistance and impaired glucose regulation [276].”
de Hoogh, I. M., Pasman, W. J., Boorsma, A., van Ommen, B., & Wopereis, S. (2022) · Biomedicines · doi:10.3390/biomedicines10030643 · Cited by 17
“As T2DM is a multi-factorial disease affecting multiple organs, and because people differ in their genetics, phenotype, lifestyle, and environment, different mechanisms may underlie T2DM pathophysiology [10,11].”
BackgroundRamorobi, L. M., Matowane, G. R., Mashele, S. S., Bonnet, S. L., Noreljaleel, A. E. M., Swain, S. S., Makhafola, T. J., & Chukwuma, C. I. (2022) · Journal of Food Biochemistry · doi:10.1111/jfbc.14360 · Cited by 13
Sinha, S., & Haque, M. (2022) · Cureus · doi:10.7759/cureus.28762 · Cited by 27
“This is expected to be accomplished by instigating the pro-inflammation of immune cells heading toward peripheral insulin resistance (IR) [90-96].”
BackgroundNabil-Adam, A., Elnosary, M. E., Ashour, M. L., Moneam, N. M. A. E., & Shreadah, M. A. (2023) · IntechOpen eBooks · doi:10.5772/intechopen.108637 · Cited by 18
Tan, J., Zhang, Z., He, Y., Yu, Y. S., Zheng, J., Liu, Y., Gong, J., Li, J., Wu, X., Zhang, S., et al. (2023) · Journal of Translational Medicine · doi:10.1186/s12967-023-03959-1 · Cited by 13
Naseralallah, L. M. A., & Aboujabal, B. (2023) · Expert Opinion on Pharmacotherapy · doi:10.1080/14656566.2023.2181074 · Cited by 18
“coronary artery disease, peripheral artery disease, and stroke) and microvascular complications (diabetic nephropathy, neuropathy, and retinopathy) [1].”
BackgroundDeligiorgi, M. V., & Trafalis, D. T. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24087630 · Cited by 13
The ameliorative effect of zinc acetate with caffeic acid in the animal model of type 2 diabetes
Matowane, G. R., Mashele, S. S., Makhafola, T. J., & Chukwuma, C. I. (2023) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2023.114779 · Cited by 13
Fan, L., Li, L., Zhao, Y. X., Zhao, Y., Wang, F., Wang, Q., Ma, Z., He, S., Qiu, J., Zhang, J., et al. (2023) · Biological Trace Element Research · doi:10.1007/s12011-023-03695-z · Cited by 13
“The pathogenesis of T2DM includes a complex combination of genetic, metabolic, and environmental factors [4].”
Iqbal, S. (2023) · Journal of Global Health Reports · doi:10.29392/001c.84191 · Cited by 31
Shoaib, S. M., Afzal, S., Feezan, A., Akash, M. S. H., Nadeem, A., & Mir, T. M. (2023) · Biomolecules · doi:10.3390/biom13091424 · Cited by 13
Cui, C., Wu, S., Chen, J., Gongpan, P., Guan, M., & Geng, C. (2023) · Journal of Agricultural and Food Chemistry · doi:10.1021/acs.jafc.3c06093 · Cited by 13
Liao, W., Cao, X., Xia, H., Wang, S., Chen, L., & Sun, G. (2023) · Frontiers in Nutrition · doi:10.3389/fnut.2023.1298046 · Cited by 16
Xia, J., Wang, Z., Yu, P., Yan, X., Zhao, J., Zhang, G., Gong, D., & Zeng, Z. (2024) · Foods · doi:10.3390/foods13020241 · Cited by 16
“T2DM is pathologically characterized by insulin resistance and early hyperinsulinemia, subsequently progressing to a decline in insulin production within pancreatic β cells [2].”
BackgroundRamos-López, O. (2024) · World Journal of Diabetes · doi:10.4239/wjd.v15.i2.142 · Cited by 19
Singh, L. S. (2024) · Pharmacological Research - Natural Products · doi:10.1016/j.prenap.2023.100004 · Cited by 22
Virus-induced diabetes mellitus: revisiting infection etiology in light of SARS-CoV-2
Jeremiah, S. S., Moin, A. S. M., & Butler, A. E. (2024) · Metabolism · doi:10.1016/j.metabol.2024.155917 · Cited by 17
Alshaikh, A. A., Al-Qahtani, F. S., Taresh, H. M. N., Hayaza, R. A. A., Alqhtani, S. S. M., Summan, S. I., Mansour, S. A. A., Alsultan, O. H. A., Asiri, H. Y. M., Alqahtani, Y. M. S., et al. (2024) · Medicina · doi:10.3390/medicina60050775 · Cited by 15
“Non-modifiable risk factors, on the other hand, include age, family history, ethnicity, and genetic predisposition [5].”
BackgroundAli, D. S., Sofela, S., Deliorman, M., Sukumar, P., Abdul-Hamid, M.-S., Yakubu, S., Rooney, C., Garrod, R., Menachery, A., Hijazi, R. A., et al. (2024) · Lab on a Chip · doi:10.1039/d3lc01016c · Cited by 13
Kim, K. J., & Kim, J. Y. (2024) · Food Science and Biotechnology · doi:10.1007/s10068-024-01607-y · Cited by 20
“Type 2 diabetes mellitus (T2DM) is characterized by elevated blood glucose levels caused by either inadequate insulin secretion or insulin resistance and accounts for more than 90% of all diabetes cases (Galicia-Garcia et al., 2020).”
Ma, L., Tang, J., Chen, F., Liu, Q., Huang, J., Liu, X., Zhou, Z., & Yi, W. (2024) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2024.116728 · Cited by 15
Brain Microvascular Pericyte Pathology Linking Alzheimer's Disease to Diabetes
El‐Ghazawi, K., Eyo, U. B., & Peirce, S. M. (2024) · Microcirculation · doi:10.1111/micc.12877 · Cited by 16
“In T2D, hyperglycemia, islet amyloid polypeptide deposits, and inflammation [4] cause microvascular dysfunction.”
Investigating the efficacy of naphthalene-thiazole hybrid hydrazones as α-glucosidase inhibitors
Al‐Humaidi, J. Y., Abouzied, A. S., Zaki, M. E. A., Abolibda, T. Z., Alruwaili, A. H., Albedair, L. A., Mukhrish, Y. E., & Gomha, S. M. (2024) · Journal of Molecular Structure · doi:10.1016/j.molstruc.2024.140288 · Cited by 13
Huamán-Castilla, N. L., Allcca-Alca, E. E., Nina, F. H., León-Calvo, N. C., Vilca, F. Z., & Vilcanqui, Y. (2024) · Molecules · doi:10.3390/molecules29215018 · Cited by 16
Purslane Ameliorates Inflammation and Oxidative Stress in Diabetes Mellitus: A Systematic Review
Nkhumeleni, Z., Phoswa, W. N., & Mokgalaboni, K. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms252212276 · Cited by 15
“The buildup of these ROS molecules and reactive nitrogen species (RNS) in mitochondria impairs its function, inducing insulin resistance and inflammation [5,10,11].”
InfluentialComposition, Anti-Diabetic, and Antioxidant Potential of Raphanus sativus Leaves
Kajszczak, D., Sosnowska, D., Frąszczak, B., & Podsędek, A. (2024) · Molecules · doi:10.3390/molecules29235689 · Cited by 17
Ahmed, S. M. I., Adnan, H., Khawaja, M. A., & Butler, A. E. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26020753 · Cited by 17
“Over time, these dysfunctional β -cells cannot counteract the effects of increasing insulin resistance, leading to inadequate insulin secretion and elevated blood glucose levels [2–4].”
Applications of AI in Predicting Drug Responses for Type 2 Diabetes
Garg, S., Kitchen, R. R., Gupta, R., & Pearson, E. R. (2025) · JMIR Diabetes · doi:10.2196/66831 · Cited by 19
“AI enables a more comprehensive analysis, by considering multiple variables and confounders simultaneously [3].”
Impact of Olive Oil Components on the Expression of Genes Related to Type 2 Diabetes Mellitus
Munteanu, C., Kotova, P. D., & Schwartz, B. (2025) · Nutrients · doi:10.3390/nu17030570 · Cited by 18
Autophagy-lysosome pathway in insulin & glucagon homeostasis
Wu, Y., Wang, H., & Xu, H. (2025) · Frontiers in Endocrinology · doi:10.3389/fendo.2025.1541794 · Cited by 23
Kajszczak, D., Kowalska-Baron, A., & Podsędek, A. (2021) · Antioxidants · doi:10.3390/antiox10060989 · Cited by 13
Riches, N. O., Gouripeddi, R., Payan-Medina, A., & Facelli, J. C. (2022) · Environmental Research · doi:10.1016/j.envres.2022.113259 · Cited by 17
Wang, W., Shi, Y., Liu, Y., Zhang, Y., Wu, J., Zhang, G., Che, Q., Zhu, T., Li, M., & Li, D. (2022) · Marine Drugs · doi:10.3390/md20050338 · Cited by 13
“Diabetes is a chronic metabolic condition marked by high blood glucose (or blood sugar) levels, which can cause catastrophic damage to the heart, blood vessels, eyes, kidneys, and nerves over time [1].”
BackgroundPlasma gelsolin levels are associated with diabetes, sex, race, and poverty
Hooten, N. N., Mode, N. A., Kowalik, E. J., Omoniyi, V., Zonderman, A. B., Ezike, N., DiNubile, M. J., Levinson, S. L., & Evans, M. K. (2023) · Journal of Translational Medicine · doi:10.1186/s12967-023-04026-5 · Cited by 13
Kinoshita, A., Nagata, T., Furuya, F., Nishizawa, M., & Mukai, E. (2023) · Heliyon · doi:10.1016/j.heliyon.2023.e14719 · Cited by 16
Xu, Q., & Cheung, R. T. F. (2023) · Brain and Behavior · doi:10.1002/brb3.3118 · Cited by 16
Discovery of Insulin is a Great Achievement for the Diabetes Patients
Mohajan, D., & Mohajan, H. K. (2023) · Studies in Social Science & Humanities · doi:10.56397/sssh.2023.08.02 · Cited by 26
Hage, K., Ma, P., Ghusn, W., Ikemiya, K., Acosta, A. J., Vierkant, R. A., Dayyeh, B. K. A., Higa, K. D., & Ghanem, O. M. (2024) · Surgical Innovation · doi:10.1177/15533506241229040 · Cited by 15
Diabetic patient assessment of chronic illness care using PACIC+
Malliarou, M. M., Desikou, C., Lahana, E., Kotrotsiou, S., Paralikas, T., Nikolentzos, A., Kotrotsiou, E., & Sarafis, P. (2020) · BMC Health Services Research · doi:10.1186/s12913-020-05400-5 · Cited by 16
Kim, H., Kim, S. R., & Jung, U. J. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26125544 · Cited by 22
Haleem, M. S., Katsarou, D., Georga, E. I., Dafoulas, G. E., Bargiota, A., Lopez-Perez, L., Rujas, M., Fico, G., Pecchia, L., Fotiadis, D., et al. (2025) · Scientific Reports · doi:10.1038/s41598-025-07272-3 · Cited by 14
The Role of the Gut Microbiome in Type 2 Diabetes Mellitus
Mashal, R., Al-Muhanna, A., Khader, S., Khudair, A. D., Khudair, A. D., & Butler, A. E. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms262311412 · Cited by 18
“Encompassing 90–95% of all global diabetes cases, T2DM is characterized by the impaired secretion of insulin from beta cells in the pancreas, along with reduced insulin sensitivity in peripheral tissues, such as skeletal muscle, liver, and adipose tissue [24,25].”
InfluentialDiabetes, sleep disorders and risk of depression - A Danish register-based cohort study
Wium‐Andersen, I. K., Jørgensen, T. S. H., Jørgensen, M. B., Osler, M., & Wium‐Andersen, M. K. (2022) · Journal of Diabetes and its Complications · doi:10.1016/j.jdiacomp.2022.108266 · Cited by 15
Pradhan, S. P., Sahu, P. K., & Behera, A. (2023) · Molecular and Cellular Biochemistry · doi:10.1007/s11010-023-04696-1 · Cited by 14
“The pathophysiology of DM consists of defective insulin secretion from pancreatic β-cells and the inability of tissues to respond to insulin [37].”
BackgroundThe Role of a Ketogenic Diet in the Treatment of Dementia in Type 2 Diabetes Mellitus
Bai, L., Zhou, Y., Zhang, J., & Ma, J. (2023) · Nutrients · doi:10.3390/nu15081971 · Cited by 12
“Type 2 DM (T2DM) is characterized by insulin resistance and accounts for 90% of all cases of diabetes [2,3].”
BackgroundCirculating MicroRNAs as Biomarker for Vessel-Associated Retinal Diseases
Dähmcke, M., Busch, M., Pfeil, J. M., Brauckmann, T., Schulz, D., Omran, W., Morawiec‐Kisiel, E., Wähler, F., Paúl, S., Tayar, A., et al. (2023) · Ophthalmologica · doi:10.1159/000533481 · Cited by 13
Seid, M. A., Diress, M., Mohammed, A., & Sinamaw, D. (2023) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2023.110905 · Cited by 13
Manzano, M., Girón, M. D., Salto, R., Burgio, C., Reinoso, A., Cabrera, E., Rueda, R., & López-Pedrosa, J. M. (2023) · Nutrients · doi:10.3390/nu15224706 · Cited by 13
“Nutrients 2023 , 15 , 4706 Muscle loss in diabetes is a multifactorial process involving several mechanisms, such as altered protein metabolism, mitochondrial dysfunction, oxidative stress, inflammation, and insulin resistance [9].”
The effect of indigenous African Diet on inflammatory markers linked to Type 2 Diabetic Mellitus
Malongane, F., Phoswa, W. N., & Berejena, T. (2023) · Human Nutrition & Metabolism · doi:10.1016/j.hnm.2023.200236 · Cited by 12
Wang, Y., Chen, H., Li, Y., Hao, H., Liu, J., Chen, Y., Meng, J., Zhang, S., Gu, W., Lyu, Z., et al. (2024) · Cytotherapy · doi:10.1016/j.jcyt.2023.12.006 · Cited by 16
Self-assembled peptide hydrogels for the treatment of diabetes and associated complications
Chavda, V. P., Teli, D., Balar, P. C., Davidson, M., Bojarska, J., Vaghela, D. A., & Apostolopoulos, V. (2024) · Colloids and Surfaces B Biointerfaces · doi:10.1016/j.colsurfb.2024.113761 · Cited by 12
Tourkmani, A. M., Alharbi, T., Rsheed, A. M. B., Alotaibi, A., Aleissa, M. S., Alotaibi, S. R., Almutairi, A. S., Thomson, J., Alshahrani, A. S., Alroyli, H. S., et al. (2024) · Telemedicine Reports · doi:10.1089/tmr.2024.0003 · Cited by 27
“2,10,11 It increased from * 108 million in 1980 to 536.6 million adults with T2DM in 2021, and this is projected to further increase to reach 783.2 million by 2045.”
BackgroundInfluentialGong, J., Yang, L., Su, Q., Zhong, W., & Xiao, J. (2024) · eFood · doi:10.1002/efd2.137 · Cited by 12
Ghandour, F., Kassem, S., Simanovich, E., & Rahat, M. A. (2024) · Biomedicines · doi:10.3390/biomedicines12040706 · Cited by 13
“Chronic hyperglycemia may lead to the glucose toxicity of cells [5,6], and therefore, we fi rst determined the range of glucose concentrations that could be used in this study without leading to cell death.”
BackgroundCorrelation of Leptin in Patients With Type 2 Diabetes Mellitus
Manglani, K., Anika, N. N., Patel, D., Jhaveri, S., Avanthika, C., Sudan, S., Alimohamed, Z., & Tiwari, K. (2024) · Cureus · doi:10.7759/cureus.57667 · Cited by 26
Bline, A. P., Ellis, L. B., Pelch, K. E., Lam, J., Sen, Ś., Zlatnik, M. G., & Varshavsky, J. (2024) · Environment International · doi:10.1016/j.envint.2024.108711 · Cited by 14
Vitamin B6 and diabetes and its role in counteracting advanced glycation end products
Vernì, F. (2024) · Vitamins and hormones · doi:10.1016/bs.vh.2024.02.005 · Cited by 17
Bertran, L., Capellades, J., Abelló, S., Aguilar, C., Auguet, T., & Richart, C. (2024) · PLoS ONE · doi:10.1371/journal.pone.0303569 · Cited by 13
Combination therapy enhances efficacy and overcomes toxicity of metal‐based anti‐diabetic agent
Shang, B., Dong, Y., Feng, B., Zhao, J., Wang, Z., Crans, D. C., & Yang, X. (2024) · British Journal of Pharmacology · doi:10.1111/bph.16485 · Cited by 13
“Progressive loss of β -cell mass and function with increasing insulin resistance are the two mutually deteriorating factors during type 2 diabetes mellitus pathogenesis (Galicia-Garcia et al., 2020).”
Natural product-based treatment potential for type 2 diabetes mellitus and cardiovascular disease
Shrivastav, D., Kumbhakar, S. K., Srivastava, S., & Singh, D. D. (2024) · World Journal of Diabetes · doi:10.4239/wjd.v15.i7.1603 · Cited by 17
From diabetes to diverse domains: the multifaceted roles of GLP-1 receptor agonists
Dave, B. P., Chorawala, M. R., Shah, I., Shah, N. N., Bhagat, S. U., Prajapati, B. G., & Thakkar, P. C. (2024) · Molecular Biology Reports · doi:10.1007/s11033-024-09793-y · Cited by 17
“GLP-1 also inhibits the activity of multiple proteins that have been associated with diabetic nephropathy, notably collagen I, alpha-smooth muscle actin (a-SMA), fibronectin (FN), and tubulointerstitial TNF-α [127, 128].”
Laurindo, L. F., Laurindo, L. F., Rodrigues, V. D., Catharin, V. M. C. S., Simili, O. A. G., Barboza, G. D. O., Catharin, V. C. S., Sloan, K. P., & Barbalho, S. M. (2024) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/s00210-024-03362-7 · Cited by 14
“Type 2 diabetes mellitus (T2DM) is a prevalent and increasingly challenging chronic condition marked by persistent hyperglycemia, resulting from defects in insu‑ lin secretion, insulin action, or both (Galicia‑Garcia et al. 2020; Laurindo et al. 2022).”
Mashayekhi‐Sardoo, H., Sepahi, S., Rahimi, V. B., & Askari, V. R. (2024) · Journal of Functional Foods · doi:10.1016/j.jff.2024.106518 · Cited by 20
Emerging Roles of ncRNAs in Type 2 Diabetes Mellitus: From Mechanisms to Drug Discovery
Yang, Y., & Cheng, H. (2024) · Biomolecules · doi:10.3390/biom14111364 · Cited by 12
Anwar, S., Alhumaydhi, F. A., Rahmani, A. H., Kumar, V., & Alrumaihi, F. (2024) · Diseases · doi:10.3390/diseases12120310 · Cited by 18
Association Between Serum Concentrations of (Certain) Metals and Type 2 Diabetes Mellitus
Tyczyńska, M., Hunek, G., Kawecka, W., Brachet, A., Gędek, M., Kulczycka, K., Czarnek, K., Flieger, J., & Baj, J. (2024) · Journal of Clinical Medicine · doi:10.3390/jcm13237443 · Cited by 19
Metadata
- Authors
- Galicia-Garcia, U., Benito-Vicente, A., Jebari, S., Larrea-Sebal, A., Siddiqi, H., Uribe, K. B., Ostolaza, H., & Martín, C.
- Affiliations
- Fundación Biofisika Bizkaia, Barrio Sarriena s/n., 48940 Leioa (Bizkaia), Spain
- Biofisika Institute (UPV/EHU, CSIC), Barrio Sarriena s/n., 48940 Leioa (Bizkaia), Spain
- Harvard University (US)
- CIC biomaGUNE (ES)
- Consejo Superior de Investigaciones Científicas (ES)
- Venue
- International Journal of Molecular Sciences
- Publisher
- MDPI AG
- Published
- 2020-08-30
- Volume
- 21
- Issue
- 17
- Pages
- 6275
- ISSN
- 1422-0067 (ISSN-L)
- PMC
- PMC7503727
- OpenAlex
- W3081655479
- Cited by
- 3,360
- References
- 297
- Citations by year
- 2026: 627 · 2025: 783 · 2024: 812 · 2023: 646 · 2022: 379 · 2021: 100 · 2020: 7
- FWCI
- 64.29
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- International Journal of Molecular Sciences (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Communities in ADDI (University of the Basque Country) (submittedVersion, other-oa)
- Communities in ADDI (Universidad del Pais Vasco) (submittedVersion, other-oa)
- LA Referencia (Red Federada de Repositorios Institucionales de Publicaciones Científicas) (submittedVersion, cc-by)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Hispana (submittedVersion, cc-by)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Pancreatic function and diabetes
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Treatment and Management
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Metabolism, Diabetes, and Cancer
- Keywords
- type 2 diabetes, insulin resistance, insulin secretion, pancreatic beta cells, insulin biosynthesis, insulin signaling, glucose homeostasis, gut dysbiosis, metabolic memory, nutrition, physical activity, atherosclerosis, cardiovascular risk
- MeSH terms
- Insulin Secretion, Animals, Blood Glucose, Diabetes Mellitus, Type 2, Homeostasis, Humans
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.